- Home
- ANEB vs CEE Comparison
ANEB vs CEE Comparison
Compare ANEB & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- CEE
- Stock Information
- Founded
- ANEB 2020
- CEE 1990
- Country
- ANEB United States
- CEE Germany
- Employees
- ANEB N/A
- CEE N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- ANEB Health Care
- CEE Finance
- Exchange
- ANEB Nasdaq
- CEE Nasdaq
- Market Cap
- ANEB 90.4M
- CEE 105.5M
- IPO Year
- ANEB 2021
- CEE N/A
- Fundamental
- Price
- ANEB $2.45
- CEE $16.03
- Analyst Decision
- ANEB Buy
- CEE
- Analyst Count
- ANEB 2
- CEE 0
- Target Price
- ANEB $8.00
- CEE N/A
- AVG Volume (30 Days)
- ANEB 127.6K
- CEE 22.0K
- Earning Date
- ANEB 11-12-2025
- CEE 01-01-0001
- Dividend Yield
- ANEB N/A
- CEE 3.86%
- EPS Growth
- ANEB N/A
- CEE N/A
- EPS
- ANEB N/A
- CEE N/A
- Revenue
- ANEB N/A
- CEE N/A
- Revenue This Year
- ANEB N/A
- CEE N/A
- Revenue Next Year
- ANEB N/A
- CEE N/A
- P/E Ratio
- ANEB N/A
- CEE N/A
- Revenue Growth
- ANEB N/A
- CEE N/A
- 52 Week Low
- ANEB $0.80
- CEE $7.80
- 52 Week High
- ANEB $3.42
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- ANEB 52.56
- CEE 44.58
- Support Level
- ANEB $2.33
- CEE $15.94
- Resistance Level
- ANEB $2.58
- CEE $16.33
- Average True Range (ATR)
- ANEB 0.16
- CEE 0.43
- MACD
- ANEB -0.00
- CEE -0.05
- Stochastic Oscillator
- ANEB 72.34
- CEE 52.02
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.